Glucagon and hepatic glucose production: modulation by low-dose bradykinin infusion.
The effect of a low-dose bradykinin (BK) infusion (30 ng/kg min) on glucagon-induced hepatic glucose production and glucose cycling was studied in five normal volunteers. Studies were performed during constant insulin concentration as achieved by simultaneous somatostatin infusion and insulin replacement. In the basal period glucagon was infused at a rate of 0.5 ng/kg min. Then, glucagon infusion rate was increased to 3 ng/kg min to test the response to hyperglucagonemia. In a second set of experiments BK was infused concomitantly with the high dose glucagon. Each subject served as his own control. BK infusion did not prevent the glucagon-induced rise in hepatic glucose production and glucose cycling. However, at a later stage BK accelerated the negative feedback mechanisms activated by glucagon (decrease in hepatic glucose production) significantly. These findings suggest that intravenous BK may interact with mechanisms involved in the down-regulation of hepatic glucagon effects.
Hartl
W H
WH
Shriners Burns Institute, Galveston, TX 77550.
Miyoshi
H
H
Elahi
D
D
Wolfe
R R
RR
D000328:Adult; D001920:Bradykinin / Q000494:pharmacology*; D002096:C-Peptide / Q000032:analysis; D005934:Glucagon / Q000096:biosynthesis*; D005947:Glucose / Q000096:biosynthesis* / Q000378:metabolism; D006439:Hemodynamics / Q000187:drug effects; D006728:Hormones / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000032:analysis; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D013004:Somatostatin / Q000008:administration & dosage
D002096:C-Peptide; D006728:Hormones; D007328:Insulin; D013004:Somatostatin; D005934:Glucagon; D005947:Glucose; D001920:Bradykinin